Psychooncology:癌症患者的孤独感研究

2015-11-01 Seven L 译 MedSci原创

研究者已对老年癌症患者的社会和情感孤独的频率和演变情况(分别与年轻癌症患者和老年非癌症患者相比)进行了研究。目前该研究团队欲探究癌症和年龄相关改变如疲劳、认知功能和功能状态,是否会对“孤独”造成影响。该研究为KLIMOP研究的一部分,包含老年癌症患者 (≥70 岁)、相对年轻的癌症患者 (50-69 岁)、以及老年非癌症患者。研究者采集了参与者的基线资料和随访1年后的资料。根据De Jong-Gi

研究者已对老年癌症患者的社会和情感孤独的频率和演变情况(分别与年轻癌症患者和老年非癌症患者相比)进行了研究。目前该研究团队欲探究癌症和年龄相关改变如疲劳、认知功能和功能状态,是否会对“孤独”造成影响。

该研究为KLIMOP研究的一部分,包含老年癌症患者 (≥70 岁)、相对年轻的癌症患者 (50-69 岁)、以及老年非癌症患者。研究者采集了参与者的基线资料和随访1年后的资料。根据De Jong-Gierveld孤独量表评估参与者孤独情况。通过多因素回顾分析评估了疲劳、认知功能和功能状态的改变与孤独的关系。

该研究纳入了475名患者,基线资料显示老年癌症患者比非癌症患者孤独感更少。随访1年后,老年癌症患者情感孤独的频率显著增加 (26-42%, p < 0.001) ,且达到了老年非癌症患者水平。年起点的癌症患者情感孤独也在增加(25-34%, p = 0.02),但是没有老年癌症患者那么多 (40-38%, p = 0.69)。社会孤独并没有什么变化。患者持续疲劳或认知功能损伤会增加孤独的风险。

研究结果表明孤独,尤其是情感孤独,是癌症患者普遍存在的问题,并且随着时间的变化,孤独感的频率也在发生变化。


在线使用:UCLA 孤独量表

原始出处:


Deckx L, van den Akker M,et al.Loneliness in patients with cancer: the first year after cancer diagnosis.Psychooncology. 2015 Nov;24(11):1521-8.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1949863, encodeId=bbdc194986388, content=<a href='/topic/show?id=56cb45442b2' target=_blank style='color:#2F92EE;'>#孤独感#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45442, encryptionId=56cb45442b2, topicName=孤独感)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad9f79, createdName=般若傻瓜, createdTime=Sat Oct 15 03:25:00 CST 2016, time=2016-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1864726, encodeId=6b411864e26b7, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Fri Jan 29 04:25:00 CST 2016, time=2016-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1674377, encodeId=5bde16e43771e, content=<a href='/topic/show?id=e8aa13359b1' target=_blank style='color:#2F92EE;'>#Oncology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13359, encryptionId=e8aa13359b1, topicName=Oncology)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb7226973259, createdName=circumcision, createdTime=Fri Apr 29 05:25:00 CST 2016, time=2016-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57130, encodeId=23625e130ad, content=给力, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160113/IMG569619FEB03536446.jpg, createdBy=85f81678980, createdName=Lynee劲飞扬, createdTime=Wed Jan 13 23:42:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1289477, encodeId=5cf312894e76b, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71356, encryptionId=cbb8e1356f7, topicName=癌症患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ba218, createdName=zgwhgch, createdTime=Tue Nov 03 11:25:00 CST 2015, time=2015-11-03, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1949863, encodeId=bbdc194986388, content=<a href='/topic/show?id=56cb45442b2' target=_blank style='color:#2F92EE;'>#孤独感#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45442, encryptionId=56cb45442b2, topicName=孤独感)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad9f79, createdName=般若傻瓜, createdTime=Sat Oct 15 03:25:00 CST 2016, time=2016-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1864726, encodeId=6b411864e26b7, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Fri Jan 29 04:25:00 CST 2016, time=2016-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1674377, encodeId=5bde16e43771e, content=<a href='/topic/show?id=e8aa13359b1' target=_blank style='color:#2F92EE;'>#Oncology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13359, encryptionId=e8aa13359b1, topicName=Oncology)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb7226973259, createdName=circumcision, createdTime=Fri Apr 29 05:25:00 CST 2016, time=2016-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57130, encodeId=23625e130ad, content=给力, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160113/IMG569619FEB03536446.jpg, createdBy=85f81678980, createdName=Lynee劲飞扬, createdTime=Wed Jan 13 23:42:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1289477, encodeId=5cf312894e76b, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71356, encryptionId=cbb8e1356f7, topicName=癌症患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ba218, createdName=zgwhgch, createdTime=Tue Nov 03 11:25:00 CST 2015, time=2015-11-03, status=1, ipAttribution=)]
    2016-01-29 minlingfeng
  3. [GetPortalCommentsPageByObjectIdResponse(id=1949863, encodeId=bbdc194986388, content=<a href='/topic/show?id=56cb45442b2' target=_blank style='color:#2F92EE;'>#孤独感#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45442, encryptionId=56cb45442b2, topicName=孤独感)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad9f79, createdName=般若傻瓜, createdTime=Sat Oct 15 03:25:00 CST 2016, time=2016-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1864726, encodeId=6b411864e26b7, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Fri Jan 29 04:25:00 CST 2016, time=2016-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1674377, encodeId=5bde16e43771e, content=<a href='/topic/show?id=e8aa13359b1' target=_blank style='color:#2F92EE;'>#Oncology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13359, encryptionId=e8aa13359b1, topicName=Oncology)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb7226973259, createdName=circumcision, createdTime=Fri Apr 29 05:25:00 CST 2016, time=2016-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57130, encodeId=23625e130ad, content=给力, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160113/IMG569619FEB03536446.jpg, createdBy=85f81678980, createdName=Lynee劲飞扬, createdTime=Wed Jan 13 23:42:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1289477, encodeId=5cf312894e76b, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71356, encryptionId=cbb8e1356f7, topicName=癌症患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ba218, createdName=zgwhgch, createdTime=Tue Nov 03 11:25:00 CST 2015, time=2015-11-03, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1949863, encodeId=bbdc194986388, content=<a href='/topic/show?id=56cb45442b2' target=_blank style='color:#2F92EE;'>#孤独感#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45442, encryptionId=56cb45442b2, topicName=孤独感)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad9f79, createdName=般若傻瓜, createdTime=Sat Oct 15 03:25:00 CST 2016, time=2016-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1864726, encodeId=6b411864e26b7, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Fri Jan 29 04:25:00 CST 2016, time=2016-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1674377, encodeId=5bde16e43771e, content=<a href='/topic/show?id=e8aa13359b1' target=_blank style='color:#2F92EE;'>#Oncology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13359, encryptionId=e8aa13359b1, topicName=Oncology)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb7226973259, createdName=circumcision, createdTime=Fri Apr 29 05:25:00 CST 2016, time=2016-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57130, encodeId=23625e130ad, content=给力, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160113/IMG569619FEB03536446.jpg, createdBy=85f81678980, createdName=Lynee劲飞扬, createdTime=Wed Jan 13 23:42:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1289477, encodeId=5cf312894e76b, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71356, encryptionId=cbb8e1356f7, topicName=癌症患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ba218, createdName=zgwhgch, createdTime=Tue Nov 03 11:25:00 CST 2015, time=2015-11-03, status=1, ipAttribution=)]
    2016-01-13 Lynee劲飞扬

    给力

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1949863, encodeId=bbdc194986388, content=<a href='/topic/show?id=56cb45442b2' target=_blank style='color:#2F92EE;'>#孤独感#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45442, encryptionId=56cb45442b2, topicName=孤独感)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad9f79, createdName=般若傻瓜, createdTime=Sat Oct 15 03:25:00 CST 2016, time=2016-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1864726, encodeId=6b411864e26b7, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Fri Jan 29 04:25:00 CST 2016, time=2016-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1674377, encodeId=5bde16e43771e, content=<a href='/topic/show?id=e8aa13359b1' target=_blank style='color:#2F92EE;'>#Oncology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13359, encryptionId=e8aa13359b1, topicName=Oncology)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb7226973259, createdName=circumcision, createdTime=Fri Apr 29 05:25:00 CST 2016, time=2016-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57130, encodeId=23625e130ad, content=给力, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160113/IMG569619FEB03536446.jpg, createdBy=85f81678980, createdName=Lynee劲飞扬, createdTime=Wed Jan 13 23:42:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1289477, encodeId=5cf312894e76b, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71356, encryptionId=cbb8e1356f7, topicName=癌症患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ba218, createdName=zgwhgch, createdTime=Tue Nov 03 11:25:00 CST 2015, time=2015-11-03, status=1, ipAttribution=)]

相关资讯

癌症小百科:历史,现状和未来点点滴滴

(一)进步和困境 一不小心跳进 “二十一世纪是生物的世纪” 这个大坑已经有十多年了,这么多年来,从本科到博士,从中国到美国,从学校到药厂,第一手,第二手,第N手的癌症研究资料接触很多。随着中国污染加剧,医疗条件改善和人们健康意识增加,周围患上癌症的人似乎越来越多。病人多,问题就多,谣言也多,鉴于最近时不时都有人咨询我各种各样关于癌症的问题,我觉得写一些科普小知识也许有些意义。朋友中很

Nature:外泌体可能是癌症播散真正的种子

了解肿瘤转移至一种特定器官而不去到其他器官处的原因是肿瘤学的首要目标之一,也是最古老的目标之一。126年前,英国医生Stephen Paget阐述了他的“种子与土壤理论”,主张转移需要肿瘤细胞传播即“种子”,和受纳器官理想的环境即“肥沃的土壤”。然而,自那时以后在阐析引导癌症转移至特异器官的机制方面一直未取得极大的进展。 近来,西班牙国家癌症中心(CNIO)微环境和癌症转移小组组长H

250年来人类抗击癌症的里程碑式进展(1775-2015)

在过去的250年间,在攻克癌症的斗争中,我们见证了许多令人瞩目的成就。这篇文章中,让我们一起回顾了一下抗癌历史中那些里程碑式的突破与进展。1775:烟囱灰和鳞状细胞癌Percivall Pott 鉴定出了扫烟囱灰的人所患的阴囊鳞状细胞癌和他们与烟囱灰长时间接触的关系。他的报告第一次把癌症的发展与环境的作用相联系。1863: 炎症和癌症Rudolph Virchow 鉴定出了肿瘤组织中的的白细胞

Psychooncology:工作可提高癌症患者生活质量

全球范围内癌症人群数量与日俱增,在人口死亡原因分析上,癌症也占了一大块江山。随着医疗的发展,癌症生存率有所提高,癌症患者的寿命相对延长,不过诊断却越来越年轻化。很多人在工作期间就诊断为癌症,之后应该辞职还是继续工作?有研究表明,癌症患者的工作状态会对其健康相关的生活质量 (HRQOL)造成显著影响。研究者纳入了2007-2012年间韩国27,089名患者,探究在长期存活的癌症患者其工作状态对HRQ

BMC Medicine:女性生殖因素与其健康状况密切相关

发表在BMC Medicine的最新研究结果表明,女性的某些生殖因素可降低女性早期死亡的风险。 生殖功能与女性内分泌系统的变化与调节密切相关。具有生殖功能对女性而言具有十分重要的意义。既往研究表明,个别生殖因素与所有类型的死亡原因或多或少都存在一定的关联,并会增加一些特定疾病的死亡风险。但是,对于生殖因素对女性长期体质和身体健康的影响,研究人员尚未可知。鉴于这些因素彼此之间都有着紧密的联系,研究人